<?xml version="1.0" encoding="UTF-8"?>
<ref id="B22-pharmaceuticals-12-00060">
 <label>22.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Willison</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Jacobs</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>van Doorn</surname>
    <given-names>P.</given-names>
   </name>
  </person-group>
  <article-title>Guillain-Barr√© Syndrome</article-title>
  <source>Lancet</source>
  <year>2016</year>
  <volume>23</volume>
  <fpage>1295</fpage>
  <lpage>1309</lpage>
  <pub-id pub-id-type="doi">10.1016/S0140-6736(16)00339-1</pub-id>
 </element-citation>
</ref>
